GLP-1 Market
LLY $1143.12 ▲ +0.0% NVO $37.54 ▲ +0.6% PFE $27.41 ▼ -1.4% VKTX $29.28 ▼ -2.2% KLRA $10.84 ▲ +4.3% GPCR $27.59 ▼ -0.3% RHHBY $52.51 ▲ +0.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Fuling Yunhua Granules

Company
Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 6, 2026

Find a Clinical Trial Near Me

See recruiting studies for Fuling Yunhua Granules and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02448992

    Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

    Not yet reported, Not yet reported Chang Gung Memorial Hospital 90 participants Est. completion 2026-12-31 1 site
    Other conditions: Non-Small-Cell Lung Cancer (NSCLC), Brain Metastasis
    View official trial listing →
  • Recruiting NCT NCT02504788

    A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline

    Not yet reported Chang Gung Memorial Hospital 100 participants Est. completion 2028-12-31 1 site
    Other conditions: Brain Metastasis, Brain Metastases
    View official trial listing →
  • Completed NCT NCT00354315

    DÉCISION+, a Continuous Professional Development Program to Improve Optimal Drug Prescription : a Feasibility Study

    Not yet reported CHU de Quebec-Universite Laval 642 participants Est. completion 2008-03 1 site
    Other conditions: Choice Behavior
    View official trial listing →
  • Status unknown NCT NCT00594360

    Evaluation of Effect of Exercise on Prescription - a Psychological Perspective

    Not yet reported, Not yet reported University of Southern Denmark 200 participants Est. completion 2008-05 1 site
    Other conditions: Physical Inactivity, Motivation, Behavior Change
    View official trial listing →
  • Status unknown NCT NCT01191164

    Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast Cancer

    Not yet reported British Columbia Cancer Agency 5 participants Est. completion 2016-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02493400

    Physiotherapist Led Group-exercise Compared Physical Activity on Prescription, a 3 Months Follow-up

    Göteborg University 87 participants Est. completion 2017-08 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03205189

    Comparison Between Pre-operative Prescription Delivered During Anesthesia Consultation or Post-operative Prescription

    Not yet reported University Hospital, Rouen 200 participants Est. completion 2018-12-31 1 site
    Other conditions: Postoperative Pain, Ambulatory Surgery, Anesthesia, Postoperative Complication
    View official trial listing →
  • Status unknown NCT NCT03223675

    Neurocognitive Impact and Dose-Effect Relationship of Hippocampal Avoidance During Whole Brain Radiotherapy Plus Simultaneous Integrated Boost - A Prospective Follow-up Study

    Not yet reported Chang Gung Memorial Hospital 100 participants Est. completion 2025-12-31 1 site
    Other conditions: Brain Metastasis, Brain Metastases
    View official trial listing →
  • Completed NCT NCT03464045

    Empa PASS on Urinary Tract Malignancies

    Boehringer Ingelheim 344995 participants Est. completion 2024-03-11 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03658044

    Social Media on Prescription for Colorectal Cancer Patients

    Not yet reported Sahlgrenska University Hospital 44 participants Est. completion 2021-10-10 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT04566250

    Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin)

    Not yet reported McMaster University 200 participants Est. completion 2022-04-01 3 sites
    Other conditions: Knee Arthroscopy, Shoulder Arthroscopy
    View official trial listing →
  • Active, not recruiting NCT NCT04765241

    mHealth Physical Activity Intervention for Young Cancer Survivors

    Not yet reported AHS Cancer Control Alberta 287 participants Est. completion 2027-05 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT05225350

    Family Meals on Prescription- a Randomized Controlled Trial

    Not yet reported Göteborg University 89 participants Est. completion 2020-09-29 1 site
    Metabolic syndrome Other conditions: Obesity, Childhood, Hypertension, Dietary Habits
    View official trial listing →
  • Active, not recruiting NCT NCT06436690

    Optimizing Antibiotics Prescription

    Not yet reported Penn State University 62 participants Est. completion 2026-12-30 2 sites
    Other conditions: Antimicrobial Resistance
    View official trial listing →
  • Completed NCT NCT06575478

    Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

    Not yet reported Beijing Supreme Life Pharmaceutical Technology Co., Ltd. 95 participants Est. completion 2025-01-27 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Type2diabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Fuling Yunhua Granules, prescription A

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.